Two cases of isolated diffuse mesangial sclerosis with WT1 mutations

Journal of Korean Medical Science

Volumn 21, Issue 1, 2006, Pages 160-164

  Hahn, Hyewon ^a   Cho, Young Mi ^a   Park, Young Seo ^a   You, Man Wook ^a   Cheong II, Hae ^b  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Denys Drash Syndrome; Diffuse Mesangial Sclerosis; Genes, Wilms Tumor; WT1 Proteins

Indexed keywords

EID: 33144464487     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2006.21.1.160     Document Type: Article

References (24)

1. Little M, Wells C. A clinical overview of WTl gene mutations. Hum Mutat 1997; 9: 209-25.
2. Dressler GR. Transcription factors in renal development: the WT1 and pax-2 story. Semin Nephrol 1995; 15: 263-71.
3. Moore AW, Mclnnes L, Kreidberg J, Hastie ND, Schedl A. YAC complementation shows a requirement for WT1 in the development of epicardium, adrenal gland and throughout nephrogenesis. Development 1999; 126: 1845-57.
4. Guo JK, Menke AL, Gubler MC, Clarke AR, Harrison D, Hammes A, Hastie ND, Schedl A. WTI is a key regulator of podocyte function: reduced expression levels cause crescentic glomerulonephritis and mesangial sclerosis. Hum Mol Genet 2002; 11: 651-9.
5. Englert C. WTI; More than a transcription factor? Trends Biochem Sci 1998; 23: 389-93.
6. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier, Houssman D, Jaenisch R. WT-1 is required for early kidney development. Cell 1993; 74: 679-91.
7. Wilhelm D, Englert C. The Wilms tumor suppressor WT1 regulates early gonad development by activation of Sf1. Genes Dev 2002; 16: 1839-51.
8. Denys P, Malvaux P, van den Berghe H, Tanghe W, Proesmans W. De pseudohermaphrodisme masculin, d'une tumeur de Wilms, d'une nephropathie parenchymateuse et d'un mosakisme XX/XY. Archives Francaises de Pediatrie 1967; 24: 729-39.
9. Drash A, Sherman F, Harmann WH, Blizzard RM. A syndrome of pseudohermaphroditism, Wilms' tumor, hypertension and degenerative renal disease. JPediatr 1970; 76: 585-93.
10. Habib R, Loirat C, Gubler MC, Niaudet P, Bensman A, Levy M, Broyer M. The nephropathy associated with male pseudohermaphroditism and. Wilms' tumor (Drash syndrome): a distinctive glomerular lesion? Report of 10 cases. Clin Nephrol 1985; 24: 269-78.
11. Jadresic L, Leake J, Gordon I, Dillon MJ, Grant DB, Pritchard J, Risdon RA, Baratt TM. Clinicopathologic review of twelve children with nephropathy, Wilms' tumor, and genital abnormalities (Drash syndrome). J Pediatr 1990; 117: 717-25.
12. Manivel JC, Sibley RK, Dehner LP. Complete and incomplete Drash syndrome: a Clinicopathologic study of five cases of a dysontogenetic-neoplastic complex. Hum Pathol 1987; 18: 80-9.
13. Hastie ND. The genetics of Wilms' tumor-a case of disrupted development. Ann Rev Genet 1994; 28: 523-58.
14. Jeanpierre C, Denamur E, Henry I, Cabanis MO, Luce S, Cecille A, Elion J, Peuchmaur M, Loirat C, Niaudet P, Gubler MC, Junien C. Identification of constitutional. WT1 mutations, in patients with isolated diffuse mesangial sclerosis and analysis ofgenotype/phenotype correlations by use of a computerized mutation database. Am J Hum Genet 1998; 62: 824-33.
15. Schumacher V, Schärer K, Wühl E, Altrogge H, Bonzel KE, Guschmann M, Neuhaus TJ, Pollastro RM, Kuwertz-Bröking E, Bulla M, Tondera AM, Mündel P, Helmchen U, Waldherr R, Weirich A, RoyerPokora B. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Kidney Int 1998; 53: 1594-600.
16. Little M, Carman G, Donaldson E. Novel WT1 exon 9 mutation (D396Y) in a patient with early onset Denys Drash syndrome. Hum Mutat 2000; 15: 389.
17. Holmberg C, Tryggvason K, Kestila MK, Jalanko HI. Congenital nephrotic syndrome. In: Avner ED, Harmon WE, Niaudet P. Pediatric Nephrology 5th ed. Philadelphia, Uppincott Williams and Wilkins, 2004; 503-16.
18. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991; 67: 437-47.
19. McElreavey K, Fellous M. Sex determination and the Y chromosome. Am J Med Genet 1999; 89: 176-85.
20. McTaggart SJ, Algar E, Chow CW, Powell HR, Jones CL Clinical spectrum of Denys-Drash and Frasier syndrome. Pediatr Nephrol 2001; 16: 335-9.
21. Demmer L, Primack W, Loik V, Brown R, Therville N, McElreavey K. Frasier syndrome: a cause of focal segmental glomerulosderosis in a 46,XX female. JAm Soc Nephrol 1999; 10: 2215-8.
22. Ito S, Ikeda M, Takada A, Kikuchi H, Hata J, Honda M. Nephrotic syndrome and end-stage renal disease with WT1 mutation detected at 3 years. Pediatr Nephrol 1999; 13: 790-1.
23. Ito S, Takata A, Hataya H, Ikeda Mikuchi H, Hata J, Honda M. Isolated diffuse mesangial sclerosis and Wilms tumor suppressor gene J Pediatr 2001; 138: 425-7.
24. Hu M, Zhang GY, Arbuckle S, Graf N, Shun A, Silink M, Lewis D, Alexander SI. Prophylactic bilateral nephrectomies in two paediatric patients with missense mutaitons in the WT1 gene. Nephrol Dial Transplant 2004; 19: 223-6.